Shire publishes plans for Dunboyne pharmaceutical plant

Shire Pharmaceuticals has published its planning application for its manufacturing facility outside Dunboyne, announced in April.
The biopharmaceutical facility is proposed for Piercetown, Craddockstown and Ballymagillen on the old N3, now the R147, and the site includes the former Peters family holding.
The plans include a two-storey production building of 17,445 square metres, to be built in two phases; a two-storey warehouse facility, also in two phases; a three-storey laboratory and administration building 12,453 square metres; car parking for 496 cars, and a temporary construction car park for 420 cars, as well as a covered bicycle for 100 bicycles.
Ancillary buildings include a bunded tank, farm, water and waste water and oil storage tanks.
The application includes the demolition of an existing two storey house and sheds. A ten-year planning application is sought, and the company has two weeks from Monday of this week to lodge the plans.
Shire plans to expand its global biotechnology manufacturing capacity over the next four years by investing US$400 million in Ireland to meet the rapidly growing demand for its highly innovative products and robust pipeline. The planned biologics manufacturing campus is expected to lead to the creation of approximately 400 permanent jobs on the 120-acre site at Dunboyne, in an area which will also see Facebook and Avoca established ovver the next few years.